Presented:

NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter

Read Now

Presented:

NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019

Read Now

Presented:

NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference

Read Now

Presented:

NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)

Read Now

Presented:

NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

Read Now

Presented:

NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

Read Now

Presented:

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

Read Now

Presented:

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

Read Now

Presented:

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

Read Now

Presented:

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

Read Now